Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03138863 · ClinicalTrials.gov registry record · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)
A NA study of Congenital Diaphragmatic Hernia and Pulmonary Hypoplasia, sponsored by Rodrigo Ruano.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT03138863: Recruiting NA study of Congenital Diaphragmatic Hernia and Pulmonary Hypoplasia, sponsored by Rodrigo Ruano.
NCT03138863 is a NA study of Congenital Diaphragmatic Hernia and Pulmonary Hypoplasia that is actively recruiting participants, run by Rodrigo Ruano. The registered enrollment target is 10 participants, below the 196-participant average among 22 other Congenital Diaphragmatic Hernia trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03138863, a NA study of Congenital Diaphragmatic Hernia and Pulmonary Hypoplasia, is actively recruiting participants, sponsored by Rodrigo Ruano.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research is to gather information on the safety and effectiveness of a new procedure called Fetoscopic Endoluminal Tracheal Occlusion (FETO).
Primary Outcome
The number of successful placement and removal of balloon during FETO procedure
Conditions Studied
Interventions
- DEVICE BALT GoldbBAL2 Detachable Balloon
- DEVICE Catheter System
Study Locations (2)
Florida
- University of Miami - Miami
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2030-11-01 |
| Phase | NA |
What NCT03138863 shows while recruiting
NCT03138863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 196-participant average among 22 other Congenital Diaphragmatic Hernia trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Congenital Diaphragmatic Hernia appearing as the primary indexed condition, and to 2 interventions - of which BALT GoldbBAL2 Detachable Balloon is the first listed.
NCT03138863 reports a single indexed study location in Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03138863 about?
NCT03138863 is a clinical study titled "Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)". The purpose of this research is to gather information on the safety and effectiveness of a new procedure called Fetoscopic Endoluminal Tracheal Occlusion (FETO).
What is the current status of trial NCT03138863?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-05-01. Estimated completion is 2030-11-01.
What conditions does trial NCT03138863 study?
This clinical trial studies the following conditions: Congenital Diaphragmatic Hernia, Pulmonary Hypoplasia, Pulmonary Artery Hypertension.
What interventions are being tested in trial NCT03138863?
The interventions under investigation include: BALT GoldbBAL2 Detachable Balloon (DEVICE), Catheter System (DEVICE).
Who is sponsoring clinical trial NCT03138863?
This trial is sponsored by Rodrigo Ruano, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03138863 being conducted?
This trial has 2 study locations across Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Diaphragmatic Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03138863's enrollment target sits among peer trials
10 18th of 22 the lowest of 22 other Congenital Diaphragmatic Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congenital Diaphragmatic Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)
RECRUITING · NA
-
Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)
RECRUITING · NA
-
Safety and Efficacy of FETO in CDH: A Phase III Trial
RECRUITING · NA
-
Trial of FETO for Severe Congenital Diaphragmatic Hernia
RECRUITING · NA
-
Fetal Endoscopic Tracheal Occlusion for CDH (CDH)
RECRUITING · NA
-
High Frequency Oscillatory Ventilation Versus High Frequency Jet Ventilation for Congenital Diaphragmatic Hernia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy